US$ 26.62
semaglutide patent expiration The upcoming expiry of the in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open Patent Expiry Day: Novo Nordisk
Description
Appetite suppression typically becomes noticeable by day 35 as the compound accumulates in your bloodstream

Lab tests may be requested if your provider deems them necessary
For patients with type 2 diabetes , discontinuation planning must address glycemic control maintenance

Check the pen has not been used or damaged
Such drugs came to prominence back in 2017, when the FDA approved Ozempic, a brand name for the drug semaglutide, which works as a diabetes treatment and has been used to help reduce body weight